Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007838
Abstract: Key Points • There are no prior prospective studies of thrombopoietin receptor agonists to enhance platelet recovery after auto-HCT.• As studied, romiplostim did not shorten the duration and depth of the platelet nadir, but it… read more here.
Keywords: label pilot; open label; study romiplostim; pilot study ... See more keywords